View of Evaluation of Humoral Immunogenicity in Diabetes Patients Six Months Post-Second Dose: Comparative Analysis of BNT162b2, ChAdOx1 nCoV-19, and BBIBP-CorV Vaccines

Return to Article Details Evaluation of Humoral Immunogenicity in Diabetes Patients Six Months Post-Second Dose: Comparative Analysis of BNT162b2, ChAdOx1 nCoV-19, and BBIBP-CorV Vaccines Download Download PDF